Journals / Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi / 2015 / Cilt: 61 - Sayı: 3

Jüvenil İdiopatik Artrit ve Ailesel Akdeniz Ateşi Birlikteliğinde Erken Tedavi ve Multidisipliner Yaklaşımın Önemi

Importance of Early and Multidisciplinary Intervention in Patients with Coexistent Juvenile Idiopathic Arthritis and Familial Mediterranean Fever

Pages
280–283
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This in turn may reduce disability and improve quality of life

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Familial Mediterranean fever (FMF) and juvenile idiopathic arthritis (JIA) are childhood-associated diseases that are rarely found to coexist.
📊
Key Findings & Data:Treatment includes non-steroidal anti-inflammatory drugs (NSAIDs), intra-articular steroid injections, immunosuppressants, increased range of motion and strength, and prevention and correction of deformities that require a multidisciplinary approach.
💡
Conclusion & Impact:This in turn may reduce disability and improve quality of life
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Familial Mediterranean fever (FMF) and juvenile idiopathic arthritis (JIA) are childhood-associated diseases that are rarely found to coexist. Treatment includes non-steroidal anti-inflammatory drugs (NSAIDs), intra-articular steroid injections, immunosuppressants, increased range of motion and strength, and prevention and correction of deformities that require a multidisciplinary approach. Here, we describe the clinical presentation, radiological findings, and management strategies of a 19-year-old male with a diagnosis of JIA and FMF presenting with musculoskeletal deformities. Coexistence of JIA and FMF has a progressive nature and can result in severe joint erosions, development of joint contractures, muscle atrophy, and osteoporosis, despite medical treatment. A multidisciplinary approach including an early and intensive rehabilitation program with regular follow-up can be considered as an important adjunct to medical treatment. This in turn may reduce disability and improve quality of life

Özet

Ailesel Akdeniz Ateşi (AAA) ve Jüvenil İdiopatik Artrit (JİA) nadiren birlikte bulunan çocukluk hastalıklarıdır. Tedavileri arasında non steroidal antiinflamatuar ilaçlar (NSAİİ), intraartiküler kortikosteroid enjeksiyonu, immünosuppresanlar, eklem hareket açıklığı ve güçlendirme egzersizleri ve deformitelerin önlenmesi yer alır. JİA ve AAA tanıları ile birlikte muskuloskeletal deformiteleri olan on dokuz yaşında erkek hastanın klinik ve radyolojik bulguları yanı sıra verilen tedavi sunulmaktadır. Medikal tedaviye rağmen, JİA ve AAA bir arada bulunduğu zaman progressif eklem erozyonu, eklem kontraktürü, kas atrofisi ve osteoporoz gelişmektedir. Bu nedenle ilaç tedavisine ek olarak mutidisipliner yaklaşım, erken ve yoğun rehabilitasyon programı ve rutin takip önem taşımaktadır. Böylece sakatlık azaltılıp hayat kalitesi arttırılabilir

🔖

Cite This Article

GÖK, H., KUTLAY, Ş., ÖZEN, S. (2022). Jüvenil İdiopatik Artrit ve Ailesel Akdeniz Ateşi Birlikteliğinde Erken Tedavi ve Multidisipliner Yaklaşımın Önemi. Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi, Cilt: 61 - Sayı: 3, 280–283. https://ajindex.com/articles/628707

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Petty RE, Southwood TR, Baum J, Bhettay E, Glass DN, Manners P, et al. Revision of the proposed classification criteria for Juvenile Idiopathic Arthritis; Durban, 1997. J Rheumatol 1998;25:1991-4.
  2. Rietschel C, Latta K. Rheumatic joint disease in childhood and ado- lescence. Orthopade 2012;41:227-40. [CrossRef] Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet 2007;369:767-78. [CrossRef] Sohar E, Gafni J, Pras M, Heller H. Familial Mediterranean Fever. A survey of 470 cases and review of the literature. Am J Med 1967;43:227-53. [CrossRef] Daniels M, Shohat T, Brenner-Ullman A, Shohat M. Familial Medi- terranean Fever: High gene frequency among the non-Ashkenaz- ic and Ashkenazic Jewish population in Israel. Am J Med Genet 1995;55:311-4. [CrossRef] Rozenbaum M, Rosner I. Severe outcome of juvenile idiopathic ar- thritis (JIA) associated with familial Mediterranean fever (FMF). Clin Exp Rheumatol 2004;22:75-8.
  3. Güler E, Kaptanoğlu E, Şahin O, Candan F, Hayta E, Elden H. Au- toantibodies are not associated with familial mediterranean fever. Acta Reumatol Port 2012;37:144-8. Cush JJ: Cytokine inhibitors.in Hochberg MC, Sılman AJ, Smolen JS, Weınblatt ME, Weisman MH (eds.): Rheumatology. 3rd ed., Edin- burg, Mosby, 2003;461-84.